Identification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendium

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Oshida, Keiyu ^a,f   Vasani, Naresh ^a   Thomas, Russell S ^b,g   Applegate, Dawn ^c   Rosen, Mitch ^a   Abbott, Barbara ^a   Lau, Christopher ^a   Guo, Grace ^d   Aleksunes, Lauren M ^d   Klaassen, Curtis ^e   Corton, J Christopher ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^c Shire Regenerative Medicine   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f TORAY INDUSTRIES INC   (Japan)

^g U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BENZOFURAN; BENZOFURAN DERIVATIVE; FENOFIBRATE; GALACTOSAMINE; LIPOPOLYSACCHARIDE; PARACETAMOL; PERFLUOROHEXANE SULFONATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIC ACID; SILICA NANOPARTICLE; TROVAFLOXACIN; UNCLASSIFIED DRUG; POLLUTANT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALORIC RESTRICTION; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; CYP4A10 GENE; FATTY LIVER; GENE; GENE EXPRESSION; INFECTION; LIVER CANCER; MALE; MEASUREMENT ACCURACY; MOUSE; NONHUMAN; PDK4 GENE; PREDICTION; ANIMAL; DIET; DRUG EFFECTS; FEMALE; GENE EXPRESSION PROFILING; KNOCKOUT MOUSE; LIVER; LIVER CELL; METABOLISM; POLLUTANT; TOXICITY;

RODENTIA;

ANIMALS; DIET; ENVIRONMENTAL POLLUTANTS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATOCYTES; INFECTION; LIVER; MALE; MICE; MICE, KNOCKOUT; PPAR ALPHA;

EID: 84923266037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112655     Document Type: Article

References (65)

1. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, et al. (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730-741. doi: 10.1002/etc.34 PMID: 20821501
2. Pery AR, Schuurmann G, Ciffroy P, Faust M, Backhaus T, et al. (2013) Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis. Sci Total Environ 456-457:307-316. doi: 10.1016/j.scitotenv. 2013.10.001 PMID: 24225422
3. Pyper SR, Viswakarma N, Yu S, Reddy JK (2010) PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal 8:e002. doi: 10.1621/nrs.08002 PMID: 20414453
4. Corton JC, Cunningham ML, Hummer BT, Lau C, Meek B, et al. (2014) Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study. Crit Rev Toxicol. Jan; 44(1):1-49. doi: 10.3109/10408444.2013.835784 PMID: 24180432
5. Peters JM, Cattley RC, Gonzalez FJ (1997) Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14, 643. Carcinogenesis 18:2029-2033. PMID: 9395198
6. Peters JM, Aoyama T, Cattley RC, Nobumitsu U, Hashimoto T, et al. (1998) Role of peroxisome proliferatoractivated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 19:1989-1994. PMID: 9855014
7. Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, et al. (2005) Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26:219-227. PMID: 15447978
8. Kawano Y, Cohen DE (2013) Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 48:434-441. doi: 10.1007/s00535-013-0758-5 PMID: 23397118
9. Tailleux A, Wouters K, Staels B (2012) Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 1821:809-818. doi: 10.1016/j.bbalip. 2011.10.016 PMID: 22056763
10. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, et al. (2000) Defect in peroxisome proliferatoractivated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 275:28918-28928. PMID: 10844002
11. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, et al. (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103:1489-1498. PMID: 10359558
12. Leone TC, Weinheimer CJ, Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96:7473-7478. PMID: 10377439
13. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, et al. (2003) Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38:123-132. PMID: 12829994
14. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, et al. (2004) Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40:972-980. PMID: 15382117
15. Howroyd P, Swanson C, Dunn C, Cattley RC, Corton JC (2004) Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha). Toxicol Pathol 32:591-599. PMID: 15603543
16. Costet P, Legendre C, More J, Edgar A, Galtier P, et al. (1998) Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273:29577-29585. PMID: 9792666
17. Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD (2001) Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 29:1467-1472. PMID: 11602523
18. Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, et al. (2001) Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 60:1189-1194. PMID: 11723225
19. Wilson CL, Miller CJ (2005) Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics. Sep. 15; 21(18):3683-5. PMID: 16076888
20. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 3:11-17. PMID: 19455231
21. Sanderson LM, De Groot PJ, Hooiveld GJ, Koppen A, Kalkhoven E, et al. (2008) Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics. PLoS One 3:e1681. doi: 10.1371/journal.pone.0001681 PMID: 18301758
22. Rakhshandehroo M, Sanderson LM, Matilainen M, Stienstra R, Carlberg C, et al. (2007) Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR Res 2007:26839. doi: 10.1155/2007/26839 PMID: 18288265
23. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, et al. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 100:12027-12032. PMID: 14512514
24. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357. PMID: 16273092
25. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. Sep. 29; 313(5795):1929-35. PMID: 17008526
26. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550. PMID: 16199517
27. Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, et al. (2010) Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5. doi: 10.1371/journal.pone.0014462 PMID: 21283510
28. Currie RA, Bombail V, Oliver JD, Moore DJ, Lim FL, et al. (2005) Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. Toxicol Sci 86:453-469. PMID: 15901911
29. Schaap MM, Zwart EP, Wackers PF, Huijskens I, Van De Water B, et al. (2012) Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes. Arch Toxicol 86:1717-1727. doi: 10.1007/s00204-012-0883-6 PMID: 22710402
30. Anderson SP, Howroyd P, Liu J, Qian X, Bahnemann R, et al. (2004) The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J Biol Chem 279:52390-52398. PMID: 15375163
31. Ross PK, Woods CG, Bradford BU, Kosyk O, Gatti DM, et al. (2009) Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver. Toxicol Appl Pharmacol 235:199-207. doi: 10.1016/j.taap. 2008.12.011 PMID: 19136022
32. Matsubara T, Tanaka N, Krausz KW, Manna SK, Kang DW, et al. (2012) Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab 16:634-644. doi: 10.1016/j.cmet.2012.10.006 PMID: 23140643
33. Aleksunes LM, Klaassen CD (2012) Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARalpha-, and Nrf2-null mice. Drug Metab Dispos 40:1366-1379. doi: 10.1124/dmd.112.045112 PMID: 22496397
34. Rosen MB, Schmid JE, Das KP, Wood CR, Zehr RD, et al. (2009) Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid. Reprod Toxicol 27:278-288. doi: 10.1016/j.reprotox.2009.01.007 PMID: 19429403
35. Rosen MB, Schmid JR, Corton JC, Zehr RD, Das KP, et al. (2010) Gene Expression Profiling in Wild-Type and PPARalpha-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARalpha-Independent Effects. PPAR Res 2010. doi: 10.1155/2010/727194 PMID: 21318169
36. Shi L, Tong W, Fang H, Scherf U, Han J, et al. (2005) Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics 6 Suppl 2:S12. PMID: 16026597
37. Hunt MC, Siponen MI, Alexson SE (2012) The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim Biophys Acta 1822:1397-1410. doi: 10. 1016/j.bbadis.2012.03.009 PMID: 22465940
38. Frohnert BI, Hui TY, Bernlohr DA (1999) Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J Biol Chem 274:3970-3977. PMID: 9933587
39. Ren H, Vallanat B, Nelson DM, Yeung LW, Guruge KS, et al. (2009) Evidence for the involvement of xenobioticresponsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species. Reprod Toxicol 27:266-277. doi: 10.1016/j.reprotox.2008.12.011 PMID: 19162173
40. De Luca JG, Doebber TW, Kelly LJ, Kemp RK, Molon-Noblot S, et al. (2000) Evidence for peroxisome proliferator-activated receptor (PPAR) alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice. Mol Pharmacol 58:470-476. PMID: 10953038
41. Corton JC, Anderson SP, Stauber A (2000) Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40:491-518. PMID: 10836145
42. Oyadomari S, Harding HP, Zhang Y, Oyadomari M, Ron D (2008) Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 7:520-532. doi: 10.1016/j.cmet.2008.04.011 PMID: 18522833
43. Thomas RS, O'Connell TM, Pluta L, Wolfinger RD, Yang L, et al. (2007) A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays. Toxicol Sci 96:40-46. PMID: 17114358
44. Bichet N, Cahard D, Fabre G, Remandet B, Gouy D, et al. (1990) Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture. Toxicol Appl Pharmacol 106:509-517. PMID: 2260097
45. Yates MS, Tran QT, Dolan PM, Osburn WO, Shin S, et al. (2009) Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 30:1024-1031. doi: 10.1093/carcin/bgp100 PMID: 19386581
46. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, et al. (2004) Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40:177-184. PMID: 15239101
47. Wu Q, Suzuki JS, Zaha H, Lin TM, Peterson RE, et al. (2008) Differences in gene expression and benzo[a]pyrene-induced DNA adduct formation in the liver of three strains of female mice with identical AhRb2 genotype treated with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and/or benzo[a]pyrene. J Appl Toxicol 28:724-733. doi: 10.1002/jat.1331 PMID: 18172886
48. He J, Hu B, Shi X, Weidert ER, Lu P, et al. (2013) Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Mol Cell Biol 33:2047-2055. doi: 10.1128/MCB.01658-12 PMID: 23508103
49. Liu HH, Lu P, Guo Y, Farrell E, Zhang X, et al. (2010) An integrative genomic analysis identifies Bhmt2 as a diet-dependent genetic factor protecting against acetaminophen-induced liver toxicity. Genome Res 20:28-35. doi: 10.1101/gr.097212.109 PMID: 19923254
50. Chen C, Krausz KW, Shah YM, Idle JR, Gonzalez FJ (2009) Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem Res Toxicol 22:699-707. doi: 10.1021/tx800464q PMID: 19256530
51. Shaw PJ, Ditewig AC, Waring JF, Liguori MJ, Blomme EA, et al. (2009) Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. Toxicol Sci 107:270-280. doi: 10.1093/toxsci/kfn205 PMID: 18930950
52. Tai ES, Bin Ali A, Zhang Q, Loh LM, Tan CE, et al. (2003) Hepatic expression of PPARalpha, a molecular target of fibrates, is regulated during inflammation in a gender-specific manner. FEBS Lett 546:237-240. PMID: 12832047
53. Ohhira M, Motomura W, Fukuda M, Yoshizaki T, Takahashi N, et al. (2007) Lipopolysaccharide induces adipose differentiation-related protein expression and lipid accumulation in the liver through inhibition of fatty acid oxidation in mice. J Gastroenterol 42:969-978. PMID: 18085354
54. Lu X, Tian Y, Zhao Q, Jin T, Xiao S, et al. (2011) Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice. Nanotechnology 22:055101. doi: 10.1088/0957-4484/22/5/055101 PMID: 21178262
55. Chen F, Zhu HH, Zhou LF, Li J, Zhao LY, et al. (2010) Genes related to the very early stage of ConA-induced fulminant hepatitis: a gene-chip-based study in a mouse model. BMC Genomics 11:240. doi: 10.1186/1471-2164-11-240 PMID: 20398290
56. Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, et al. (2012) Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 55:395-407. doi: 10.1002/hep. 24685 PMID: 21932408
57. Mohapatra SK, Cole LE, Evans C, Sobral BW, Bassaganya-Riera J, et al. (2010) Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection. BMC Infect Dis 10:10. doi: 10.1186/1471-2334-10-10 PMID: 20082697
58. Diani-Moore S, Ma Y, Gross SS, Rifkind AB (2014) Increases in Levels of Epoxyeicosatrienoic and Dihydroxyeicosatrienoic Acids (EETs and DHETs) in Liver and Heart in Vivo by 2, 3, 7, 8-Tetrachlorodibenzop-Dioxin (TCDD) and in Hepatic EET: DHET Ratios by Cotreatment with TCDD and the Soluble Epoxide Hydrolase Inhibitor AUDA. Drug Metab Dispos 42:294-300. doi: 10.1124/dmd.113.055368 PMID: 24311719
59. Cowart LA, Wei S, Hsu MH, Johnson EF, Krishna MU, et al. (2002) The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J Biol Chem 277:35105-35112. PMID: 12124379
60. Sakai M, Matsushima-Hibiya Y, Nishizawa M, Nishi S (1995) Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun. and peroxisome proliferator-activated receptor alpha. Cancer Res 55:5370-5376. PMID: 7585603
61. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, et al. (1999) Peroxisome proliferatoractivated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274:32048-32054. PMID: 10542237
62. Inoue I, Itoh F, Aoyagi S, Tazawa S, Kusama H, et al. (2002) Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB. Biochem Biophys Res Commun 290:131-139. PMID: 11779144
63. Fisher P, Hedeler C, Wolstencroft K, Hulme H, Noyes H, et al. (2007) A systematic strategy for largescale analysis of genotype phenotype correlations: identification of candidate genes involved in African trypanosomiasis. Nucleic Acids Res 35:5625-5633. PMID: 17709344
64. Galindo CL, Moen ST, Kozlova EV, Sha J, Garner HR, et al. (2009) Comparative Analyses of Transcriptional Profiles in Mouse Organs Using a Pneumonic Plague Model after Infection with Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant. Comp Funct Genomics 2009:914762. doi: 10.1155/2009/914762 PMID: 20145715
65. Thomas AM, Hart SN, Kong B, Fang J, Zhong XB, et al. (2010) Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology. 51(4):1410-9. doi: 10.1002/hep. 23450 PMID: 20091679